Analysis of Th1, Th17 and regulatory T cells in tuberculosis case contacts

Cellular Immunology

Volumn 289, Issue 1-2, 2014, Pages 167-173

  Garcia Jacobo R E ^a   Serrano, C J ^a   Enciso Moreno, J A ^a   Gaspar Ramirez O ^c   Trujillo Ochoa, J L ^a   Uresti Rivera, E E ^b   Portales Perez D P ^b   Gonzalez Amaro R ^d   Garcia Hernandez M H ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c Avanzados SC Unidad Monterrey   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Immune response; Mycobacteria; T lymphocytes; TB spectrum; Tuberculosis case contacts

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MYCOBACTERIUM ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; BACTERIAL IMMUNITY; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; IN VITRO STUDY; INTERFERON GAMMA RELEASE ASSAY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TUBERCULOSIS;

IMMUNE RESPONSE; MYCOBACTERIA; T LYMPHOCYTES; TB SPECTRUM; TUBERCULOSIS CASE CONTACTS;

ADULT; ANTIGENS, CD4; CTLA-4 ANTIGEN; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84900820678     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.03.010     Document Type: Article

References (51)

1. Orcau A., Cayla J.A., Martinez J.A. Present epidemiology of tuberculosis. Prevention and control programs. Enferm. Infecc. Microbiol. Clin. 2011, 29(Suppl. 1):2-7.
2. Horsburgh C.R. Priorities for the treatment of latent tuberculosis infection in the United States. N. Engl. J. Med. 2004, 350:2060-2067.
3. Radhakrishna S., Frieden T.R., Subramani R. Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in south India: a 15-year follow-up. Int. J. Tuberc. Lung Dis. 2003, 7:1083-1091.
4. Barry C.E., Boshoff H.I., Dartois V., Dick T., Ehrt S., Flynn J., Schnappinger D., Wilkinson R.J., Young D. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 2009, 7:845-855.
5. Lawn S.D., Zumla A.I. Tuberculosis. Lancet 2011, 378:57-72.
6. Diel R., Loddenkemper R., Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 2012, 142:63-75.
7. Higuchi K. QFT test and TST test in diagnosis of TB infection. Nihon Rinsho 2011, 69:1378-1383.
8. Khurana A.K., Khurana U. The journey from latent to active TB: no roadmaps as yet. Chest 2012, 142:811. author reply 811-812.
9. Manuel O., Humar A., Preiksaitis J., Doucette K., Shokoples S., Peleg A.Y., Cobos I., Kumar D. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am. J. Transplant. 2007, 7:2797-2801.
10. Pai M. Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes. Nat. Rev. Microbiol. 2010, 8:242. author reply 242.
11. Soysal A., Millington K.A., Bakir M., Dosanjh D., Aslan Y., Deeks J.J., Efe S., Staveley I., Ewer K., Lalvani A. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005, 366:1443-1451.
12. Burl S., Hill P.C., Jeffries D.J., Holland M.J., Fox A., Lugos M.D., Adegbola R.A., Rook G.A., Zumla A., McAdam K.P., Brookes R.H. FOXP3 gene expression in a tuberculosis case contact study. Clin. Exp. Immunol. 2007, 149:117-122.
13. Hill P.C., Brookes R.H., Fox A., Jackson-Sillah D., Jeffries D.J., Lugos M.D., Donkor S.A., Adetifa I.M., de Jong B.C., Aiken A.M., Adegbola R.A., McAdam K.P. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 2007, 4:e192.
14. Ariga H., Harada N. Evolution of IGRA researches. Kekkaku 2008, 83:641-652.
15. Harada N. Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay. Kekkaku 2006, 81:681-686.
16. Stavri H., Bucurenci N., Ulea I., Costache A., Popa L., Popa M.I. Use of recombinant purified protein derivative (PPD) antigens as specific skin test for tuberculosis. Indian J. Med. Res. 2012, 136:799-807.
17. Pai M., Joshi R., Dogra S., Mendiratta D.K., Narang P., Kalantri S., Reingold A.L., Colford J.M., Riley L.W., Menzies D. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am. J. Respir. Crit. Care Med. 2006, 174:349-355.
18. Yoshiyama T., Harada N., Higuchi K., Nakajima Y., Ogata H. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays. Epidemiol. Infect. 2009, 137:1691-1698.
19. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 1996, 335:1941-1949.
20. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993, 178:2249-2254.
21. Holland S.M. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Immunol. Res. 2007, 38:342-346.
22. Cooper A.M. Editorial: Be careful what you ask for: is the presence of IL-17 indicative of immunity?. J. Leukoc. Biol. 2010, 88:221-223.
23. Larson R.P., Shafiani S., Urdahl K.B. Foxp3(+) regulatory T cells in tuberculosis. Adv. Exp. Med. Biol. 2013, 783:165-180.
24. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl. 1):S62-69.
25. Yaqoob P., Newsholme E.A., Calder P.C. Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells. Cytokine 1999, 11:600-605.
26. Damsgaard C.T., Lauritzen L., Calder P.C., Kjaer T.M., Frokiaer H. Whole-blood culture is a valid low-cost method to measure monocytic cytokines - a comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes. J. Immunol. Methods 2009, 340:95-101.
27. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 2002, 20:581-620.
28. Ottenhoff T.H., Verreck F.A., Lichtenauer-Kaligis E.G., Hoeve M.A., Sanal O., van Dissel J.T. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 2002, 32:97-105.
29. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., Shen F., Eaton S.M., Gaffen S.L., Swain S.L., Locksley R.M., Haynes L., Randall T.D., Cooper A.M. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007, 8:369-377.
30. Babu S., Bhat S.Q., Kumar N.P., Kumaraswami V., Nutman T.B. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J. Infect. Dis. 2010, 201:20-31.
31. Fan L., Xiao H.P., Hu Z.Y., Ernst J.D. Variation of Mycobacterium tuberculosis antigen-specific IFN-gamma and IL-17 responses in healthy tuberculin skin test (TST)-positive human subjects. PLoS One 2012, 7:e42716.
32. Ribeiro S., Dooley K., Hackman J., Loredo C., Efron A., Chaisson R.E., Conde M.B., Boechat N., Dorman S.E. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect. Dis. 2009, 9:23.
33. Aiken A.M., Hill P.C., Fox A., McAdam K.P., Jackson-Sillah D., Lugos M.D., Donkor S.A., Adegbola R.A., Brookes R.H. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect. Dis. 2006, 6:66.
34. Barnes P.F., Mistry S.D., Cooper C.L., Pirmez C., Rea T.H., Modlin R.L. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 1989, 142:1114-1119.
35. Lin P.L., Flynn J.L. Understanding latent tuberculosis: a moving target. J. Immunol. 2010, 185:15-22.
36. Sutherland J.S., Adetifa I.M., Hill P.C., Adegbola R.A., Ota M.O. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 2009, 39:723-729.
37. Cowan J., Pandey S., Filion L.G., Angel J.B., Kumar A., Cameron D.W. Comparison of interferon-gamma-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clin. Exp. Immunol. 2012, 167:317-329.
38. Salgame P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 2005, 17:374-380.
39. Kawamura I. Protective immunity against Mycobacterium tuberculosis. Kekkaku 2006, 81:687-691.
40. Chen X., Zhang M., Liao M., Graner M.W., Wu C., Yang Q., Liu H., Zhou B. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am. J. Respir. Crit. Care Med. 2010, 181:734-742.
41. Wozniak T.M., Saunders B.M., Ryan A.A., Britton W.J. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect. Immun. 2010, 78:4187-4194.
42. Wozniak T.M., Ryan A.A., Britton W.J. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J. Immunol. 2006, 177:8684-8692.
43. Wozniak T.M., Ryan A.A., Triccas J.A., Britton W.J. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect. Immun. 2006, 74:557-565.
44. Yamashita Y., Hoshino Y., Oka M., Matsumoto S., Ariga H., Nagai H., Makino M., Ariyoshi K., Tsunetsugu-Yokota Y. Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens. Jpn. J. Infect. Dis. 2013, 66:207-215.
45. Yamaguchi T., Kishi A., Osaki M., Morikawa H., Prieto-Martin P., Wing K., Saito T., Sakaguchi S. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Proc. Natl. Acad. Sci. USA 2013, 110:E2116-E2125.
46. Maggi E., Cosmi L., Liotta F., Romagnani P., Romagnani S., Annunziato F. Thymic regulatory T cells. Autoimmun. Rev. 2005, 4:579-586.
47. Tai X., Van Laethem F., Pobezinsky L., Guinter T., Sharrow S.O., Adams A., Granger L., Kruhlak M., Lindsten T., Thompson C.B., Feigenbaum L., Singer A. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 2012, 119:5155-5163.
48. Garcia-Hernandez M.H., Alvarado-Sanchez B., Calvo-Turrubiartes M.Z., Salgado-Bustamante M., Rodriguez-Pinal C.Y., Gamez-Lopez L.R., Gonzalez-Amaro R., Portales-Perez D.P. Regulatory T Cells in children with intestinal parasite infection. Parasite Immunol. 2009, 31:597-603.
49. Pornprasert S., Leechanachai P., Klinbuayaem V., Leenasirimakul P., Promping C., Inta P., Ajhan S. Unmasking tuberculosis-associated immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy. Asian Pac. J. Allergy Immunol. 2010, 28:206-209.
50. Bocchino M., Sanduzzi A., Bariffi F. Mycobacterium tuberculosis and HIV co-infection in the lung: synergic immune dysregulation leading to disease progression. Monaldi Arch. Chest Dis. 2000, 55:381-388.
51. Garg A., Barnes P.F., Roy S., Quiroga M.F., Wu S., Garcia V.E., Krutzik S.R., Weis S.E., Vankayalapati R. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur. J. Immunol. 2008, 38:459-469.